1 story tagged “Pancreatic Cancer”
The FDA has granted approval for the drug Rasonque, a targeted therapy designed to extend the lives of patients with advanced pancreatic cancer. While the drug offers a new clinical option, the manufacturer has not yet disclosed pricing, leaving the potential financial impact on public health systems and taxpayers uncertain.
